Literature DB >> 18495777

Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression.

Shih-Shin Chang1, You-Chang Lo, Huey-Huey Chua, Hsin-Yi Chiu, Shu-Chun Tsai, Jen-Yang Chen, Kwok-Wai Lo, Ching-Hwa Tsai.   

Abstract

The tumor suppressor gene p53 plays a central role in the maintenance of normal cell growth and genetic integrity, while its impact on the Epstein-Barr virus (EBV) life cycle remains elusive. We found that p53 is important for histone deacetylase inhibitor-induced EBV lytic gene expression in nasopharyngeal carcinoma cells. Restoration of p53 in p53-null, EBV-infected H1299 cells augments the potential for viral lytic cycle initiation. Evidence from reporter assays demonstrated that p53 contributes to the expression of the immediate-early viral Zta gene. Further analysis indicated that the DNA-binding ability of p53 and phosphorylation of Ser392 may be critical. This study provides the first evidence that p53 is involved in the regulation of EBV lytic cycle initiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495777      PMCID: PMC2493335          DOI: 10.1128/JVI.02717-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.

Authors:  Y Chang; C H Tung; Y T Huang; J Lu; J Y Chen; C H Tsai
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Potential role for p53 in the permissive life cycle of human cytomegalovirus.

Authors:  N C Casavant; M H Luo; K Rosenke; T Winegardner; A Zurawska; E A Fortunato
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.

Authors:  Mathieu Pampin; Yannick Simonin; Bruno Blondel; Yann Percherancier; Mounira K Chelbi-Alix
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.

Authors:  Wen-hai Feng; Bruce Israel; Nancy Raab-Traub; Pierre Busson; Shannon C Kenney
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

5.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

6.  The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms.

Authors:  Amy Mauser; Shin'ichi Saito; Ettore Appella; Carl W Anderson; William T Seaman; Shannon Kenney
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  p53 promotes adenoviral replication and increases late viral gene expression.

Authors:  J A Royds; M Hibma; B R Dix; L Hananeia; I A Russell; A Wiles; D Wynford-Thomas; A W Braithwaite
Journal:  Oncogene       Date:  2006-03-09       Impact factor: 9.867

8.  Inhibition of HIV-1 replication by RNA interference of p53 expression.

Authors:  Eduardo Pauls; Jordi Senserrich; Bonaventura Clotet; Jose A Esté
Journal:  J Leukoc Biol       Date:  2006-07-14       Impact factor: 4.962

9.  Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.

Authors:  Chih-Hung Hsu; Manfred Hergenhahn; Shuan-En Chuang; Pei-Yen Yeh; Ta-Chung Wu; Ming Gao; Ann-Lii Cheng
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

10.  CDK9 phosphorylates p53 on serine residues 33, 315 and 392.

Authors:  Senthil K Radhakrishnan; Andrei L Gartel
Journal:  Cell Cycle       Date:  2006-03-01       Impact factor: 4.534

View more
  17 in total

Review 1.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

2.  p53 Is a Host Cell Regulator during Herpes Simplex Encephalitis.

Authors:  Yuhei Maruzuru; Naoto Koyanagi; Naoki Takemura; Satoshi Uematsu; Daisuke Matsubara; Yutaka Suzuki; Jun Arii; Akihisa Kato; Yasushi Kawaguchi
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

3.  The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli.

Authors:  Stacy R Hagemeier; Elizabeth A Barlow; Qiao Meng; Shannon C Kenney
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

4.  Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.

Authors:  Pei-Fang Tsai; Sue-Jane Lin; Pei-Lun Weng; Shu-Chun Tsai; Jiun-Han Lin; Ya-Ching Chou; Ching-Hwa Tsai
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

5.  The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner.

Authors:  Stacy R Hagemeier; Elizabeth A Barlow; Ariel A Kleman; Shannon C Kenney
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

6.  Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.

Authors:  Kelly L Gorres; Derek Daigle; Sudharshan Mohanram; George Miller
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

7.  Roles of p53 in herpes simplex virus 1 replication.

Authors:  Yuhei Maruzuru; Hikaru Fujii; Masaaki Oyama; Hiroko Kozuka-Hata; Akihisa Kato; Yasushi Kawaguchi
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

Review 8.  Noise cancellation: viral fine tuning of the cellular environment for its own genome replication.

Authors:  Yoshitaka Sato; Tatsuya Tsurumi
Journal:  PLoS Pathog       Date:  2010-12-16       Impact factor: 6.823

9.  The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output.

Authors:  Vey Hadinoto; Michael Shapiro; Chia Chi Sun; David A Thorley-Lawson
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

10.  Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.

Authors:  Richard J Kraus; Blue-Leaf A Cordes; Saraniya Sathiamoorthi; Parita Patel; Xueying Yuan; Tawin Iempridee; Xianming Yu; Denis L Lee; Paul F Lambert; Janet E Mertz
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.